This network of proinflammatory components competes with inhibitory effect of anti-inflammatory cytokines (IL-4) on breast cancer cells growth [22] and promotes cell proliferation, tumorigenesis and metastasis [19]. The gene discussed is IL4; the disease is breast carcinoma.